FDA Greenlights Balfaxar for Warfarin Reversal FDA Greenlights Balfaxar for Warfarin Reversal
Balfaxar helps restore blood coagulation by replenishing the levels of clotting factors.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - October 3, 2023 Category: Primary Care Tags: Emergency Medicine Source Type: news
How To Avoid China ’ s Medicine Monopoly
I want to share a shocking statistic with you…
Around 80% of all the pharmaceuticals sold in America — both prescription and over-the-counter — are manufactured in China.
I’m talking about drugs for Parkinson’s and Alzheimer’s, blood pressure and blood thinners, diuretics, aspirin, antibiotics, and a big chunk of the world’s insulin and diabetes drugs — just to name a few.1
We don’t even make penicillin anymore. The last penicillin plant in the U.S. closed its doors in 2004.
Americans who rely on medicine are now almost entirely at the mercy of a country whose relations with the U.S. have become more ...
Source: Al Sears, MD Natural Remedies - September 19, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Source Type: news
DOACs Reduce Dementia Risk Versus Warfarin in A-Fib
THURSDAY, Sept. 7, 2023 -- For patients with atrial fibrillation (AF), the use of direct-acting oral anticoagulants (DOACs) significantly reduces dementia risk compared with warfarin, according to a systematic review and meta-analysis published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 7, 2023 Category: Pharmaceuticals Source Type: news
Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 -- Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2023 Category: Pharmaceuticals Source Type: news
Rush to DOACs Spells Trouble for Frail Warfarin Users
(MedPage Today) -- AMSTERDAM -- Best let frail older people who are stable on international normalized ratio (INR)-guided vitamin K antagonist (VKA) management stay on it instead of switching to a direct oral anticoagulant (DOAC or NOAC), the... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 28, 2023 Category: Cardiology Source Type: news
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
MONDAY, Aug. 21, 2023 -- For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2023 Category: Pharmaceuticals Source Type: news
FDA Approves Balfaxar (prothrombin complex concentrate, human-lans) for Warfarin Reversal in Urgent Surgery & Invasive Procedures
PARAMUS, N.J., July 26, 2023 /PRNewswire/ -- Octapharma USA today announced that Balfaxar® (prothrombin complex concentrate, human-lans; marketed in Europe and Canada as octaplex®) has received U.S. Food and Drug Administration (FDA)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 26, 2023 Category: Drugs & Pharmacology Source Type: news
Risk for Single-Positive LAC Results With Anticoagulants Risk for Single-Positive LAC Results With Anticoagulants
Should lupus anticoagulant testing be avoided in patients receiving anticoagulation with DOACs or warfarin, due to potential false-positive results?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 30, 2023 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Standard-Dose DOAC Better for Kidney-Impaired Patients
(MedPage Today) -- Standard-dose direct oral anticoagulants (DOACs) safely bested both lower doses and warfarin among patients with kidney dysfunction in subgroup analysis across pivotal clinical trials in atrial fibrillation (AF).
The benefit... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 13, 2023 Category: Cardiology Source Type: news
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Pharmacogenomics in Stroke and Cardiovascular Disease Pharmacogenomics in Stroke and Cardiovascular Disease
This review provides an overview of the genetic variants that influence individual responses to aspirin, clopidogrel, warfarin, and statins and the clinical implications for stroke patients.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Warfarin Best for Thrombotic Antiphospholipid Syndrome? Warfarin Best for Thrombotic Antiphospholipid Syndrome?
Patients with thrombotic antiphospholipid syndrome appear better treated with a vitamin K antagonist such as warfarin, rather than a direct oral anticoagulant, a new meta-analysis suggests.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - January 10, 2023 Category: Primary Care Tags: Cardiology News Source Type: news
Risk of bleeding after ground-level falls in elderly patients with atrial fibrillation and warfarin therapy - Bezak B, Vachalcova MB, Kissova V, Michalek P, Stevlik J, Jackuliak P, Stevove M, Uher T, Bohm A.
OBJECTIVES: The aim of this study was to investigate bleeding risk in patients treated with VKAs after ground-level falls, considering the type and severity of bleeding. METHODS: The study was designed as a retrospective cohort study and included a... (Source: SafetyLit)
Source: SafetyLit - January 9, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Real-World Study Confirms Benefit of XARELTO ® (rivaroxaban) for Secondary Prevention of Venous Thromboembolism in Cancer Patients
TITUSVILLE, NJ, December 9, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced observational data from eight years of clinical practice showing that the oral Factor Xa inhibitor XARELTO® (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a broad cohort of patients with various cancer types. Patients with CAT are at a higher risk of venous thromboembolism (VTE), which is the second-leading cause of death in people with cancer.1Data from the Observational Study in Cancer-A...
Source: Johnson and Johnson - December 9, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
Delayed intracranial hemorrhage after head injury among elderly patients on anticoagulation seen in the emergency department - Liu S, McLeod SL, Atzema CL, Austin PC, de Wit K, Sharma S, Mittmann N, Borgundvaag B, Grewal K.
INTRODUCTION: Elderly patients on oral anticoagulation are commonly seen in emergency departments (EDs). Oral anticoagulation, particularly warfarin, is associated with an increased risk of intracranial hemorrhage after head trauma. Data on delayed bleeds ... (Source: SafetyLit)
Source: SafetyLit - October 18, 2022 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
